Moderna (MRNA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

Moderna (MRNA) reported $1.86 billion in revenue for the quarter ended September 2024, representing a year-over-year increase of 1.7$0.03 for the same period compares to -$1.39 a year ago.The reported revenue represents a surprise of +47.73$1.26 billion. With the consensus EPS estimate being -$1.89, the EPS surprise was +101.59%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Str ...